Little House Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.38M | Buy |
26,318
+842
| +3% | +$98.6K | 0.76% | 35 |
|
|
2026
Q1 | $3.06M | Buy |
25,476
+11,861
| +87% | +$1.37M | 0.79% | 36 |
|
|
2025
Q4 | $1.43M | Sell |
13,615
-1,806
| -12% | -$170K | 0.36% | 61 |
|
|
2025
Q3 | $1.29M | Sell |
15,421
-9,815
| -39% | -$808K | 0.3% | 71 |
|
|
2025
Q2 | $2M | Buy |
25,236
+308
| +1% | +$24.5K | 0.5% | 51 |
|
|
2025
Q1 | $2.24M | Buy |
24,928
+697
| +3% | +$65.1K | 0.62% | 47 |
|
|
2024
Q4 | $2.41M | Sell |
24,231
-6,120
| -20% | -$631K | 0.69% | 41 |
|
|
2024
Q3 | $3.45M | Buy |
30,351
+1,399
| +5% | +$166K | 0.99% | 29 |
|
|
2024
Q2 | $3.58M | Sell |
28,952
-56
| -0.2% | -$7.21K | 1.12% | 24 |
|
|
2024
Q1 | $3.83M | Buy |
29,008
+1,065
| +4% | +$131K | 1.27% | 23 |
|
|
2023
Q4 | $3.05M | Buy |
27,943
+28
| +0.1% | +$2.91K | 1.11% | 27 |
|
|
2023
Q3 | $2.87M | Buy |
27,915
+4,000
| +17% | +$431K | 1.18% | 23 |
|
|
2023
Q2 | $2.76M | Buy |
23,915
+907
| +4% | +$103K | 1.17% | 24 |
|
|
2023
Q1 | $2.45M | Sell |
23,008
-6,300
| -21% | -$680K | 1.15% | 26 |
|
|
2022
Q4 | $3.25M | Buy |
29,308
+783
| +3% | +$80K | 1.61% | 18 |
|
|
2022
Q3 | $2.46M | Buy |
28,525
+2,575
| +10% | +$230K | 1.31% | 22 |
|
|
2022
Q2 | $2.37M | Buy |
25,950
+4,571
| +21% | +$405K | 1.27% | 25 |
|
|
2022
Q1 | $1.75M | Buy |
21,379
+5,756
| +37% | +$454K | 0.9% | 36 |
|
|
2021
Q4 | $1.2M | Sell |
15,623
-28
| -0.2% | -$2.23K | 0.63% | 52 |
|
|
2021
Q3 | $1.18M | Sell |
15,651
-321
| -2% | -$24.4K | 0.69% | 43 |
|
|
2021
Q2 | $1.24M | Sell |
15,972
-27,879
| -64% | -$2.07M | 0.67% | 50 |
|
|
2021
Q1 | $3.23M | Buy |
43,851
+38,621
| +738% | +$2.85M | 1.14% | 32 |
|
|
2020
Q4 | $408K | Buy |
5,230
+412
| +9% | +$31.5K | 0.3% | 73 |
|
|
2020
Q3 | $381K | Hold |
4,818
| – | – | 0.32% | 73 |
|
|
2020
Q2 | $355K | Sell |
4,818
-815
| -14% | -$61.4K | 0.33% | 74 |
|
|
2020
Q1 | $414K | Sell |
5,633
-103
| -2% | -$8.1K | 0.45% | 56 |
|
|
2019
Q4 | $501K | Buy |
5,736
+937
| +20% | +$77K | 0.43% | 67 |
|
|
2019
Q3 | $388K | Buy |
4,799
+75
| +2% | +$6.01K | 0.29% | 85 |
|
|
2019
Q2 | $370K | Buy |
4,724
+37
| +0.8% | +$2.83K | 0.25% | 86 |
|
|
2019
Q1 | $374K | Sell |
4,687
-48
| -1% | -$3.59K | 0.28% | 82 |
|
|
2018
Q4 | $348K | Buy |
+4,735
| New | +$334K | 0.34% | 81 |
|
Other funds holding MRK
Little House Capital's MRK Position: Q2 2026 in Review
Little House Capital increased its Merck (MRK) stake by 3.3% in Q2 2026, buying an estimated $98.6K and bringing the position to 26,318 shares worth $3.38M. The position accounts for 0.76% of the portfolio, ranked #35.
Little House Capital first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.83M in Q1 2024. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Little House Capital held 26,318 shares of Merck worth $3.38M as of Q2 2026.
- Little House Capital bought 842 Merck shares in Q2 2026, an estimated $98.6K.
- Merck made up 0.76% of Little House Capital's portfolio in Q2 2026, its #35 holding.
- Little House Capital first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Little House Capital's Merck position peaked at $3.83M in Q1 2024.
- 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Little House Capital's 13F filing for Q2 2026, filed 7 Aug 2026.